Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Artiva Biotherapeutics Revenue
Artiva Biotherapeutics had revenue of $32.75M in the twelve months ending March 31, 2024. In the year 2023, Artiva Biotherapeutics had annual revenue of $33.49M with 579.21% growth.
Revenue (ttm)
$32.75M
Revenue Growth
+579.21%
P/S Ratio
n/a
Revenue / Employee
$404,370
Employees
81
Market Cap
n/a
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 33.49M | 28.56M | 579.21% |
| Dec 31, 2022 | 4.93M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionARTV News
- 6 days ago - Autoimmune biotech Artiva Biotherapeutics refiles for a $100 million IPO, following attempt in 2021 - Renaissance Capital
- 6 days ago - Artiva Biotherapeutics IPO Registration Document (S-1) - SEC